These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31707876)

  • 21. Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus.
    Tschöpe D; Bramlage P; Schneider S; Gitt AK
    Diab Vasc Dis Res; 2016 Jan; 13(1):2-12. PubMed ID: 26567123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.
    Garber A; Marre M; Blonde L; Allavoine T; Howlett H; Lehert P; Cornes M
    Diabetes Obes Metab; 2003 May; 5(3):171-9. PubMed ID: 12681024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea.
    Lukashevich V; Del Prato S; Araga M; Kothny W
    Diabetes Obes Metab; 2014 May; 16(5):403-9. PubMed ID: 24199686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin: an antihyperglycemic drug for non-insulin-dependent diabetes mellitus.
    Kupecz D
    Nurse Pract; 1995 Jul; 20(7):70-2. PubMed ID: 7675343
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 26. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
    Cook MN; Girman CJ; Stein PP; Alexander CM
    Diabet Med; 2007 Apr; 24(4):350-8. PubMed ID: 17335466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.
    Del Prato S; Camisasca R; Wilson C; Fleck P
    Diabetes Obes Metab; 2014 Dec; 16(12):1239-46. PubMed ID: 25132212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycaemic control: a balancing act or a different approach?
    Fava S
    Curr Diabetes Rev; 2014 Mar; 10(2):124-30. PubMed ID: 24745817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states.
    McAlister FA; Lethebe BC; Lambe C; Williamson T; Lowerison M
    Cardiovasc Diabetol; 2018 Feb; 17(1):27. PubMed ID: 29433515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
    Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
    Rosenstock J; Rood J; Cobitz A; Huang C; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):643-9. PubMed ID: 17026488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.
    Wilding JP; Woo V; Rohwedder K; Sugg J; Parikh S;
    Diabetes Obes Metab; 2014 Feb; 16(2):124-36. PubMed ID: 23911013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.
    Bajaj M; Gilman R; Patel S; Kempthorne-Rawson J; Lewis-D'Agostino D; Woerle HJ
    Diabet Med; 2014 Dec; 31(12):1505-14. PubMed ID: 24824197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?
    Mathur S; Zammitt NN; Frier BM
    Drug Saf; 2015 Jan; 38(1):17-32. PubMed ID: 25481812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme.
    Broglio F; Mannucci E; Napoli R; Nicolucci A; Purrello F; Nikonova E; Stager W; Trevisan R
    Diabetes Obes Metab; 2017 Feb; 19(2):248-256. PubMed ID: 27762096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are elderly patients with diabetes being overtreated in French long-term-care homes?
    Bouillet B; Vaillant G; Petit JM; Duclos M; Poussier A; Brindisi MC; Vergès B
    Diabetes Metab; 2010 Sep; 36(4):272-7. PubMed ID: 20363171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.
    Yale JF; Aroda VR; Charbonnel B; Sinclair AJ; Trescoli C; Cahn A; Bigot G; Merino-Trigo A; Brulle-Wohlhueter C; Bolli GB; Ritzel R
    Diabetes Metab; 2020 Apr; 46(2):110-118. PubMed ID: 30366067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing hyperglycaemia.
    Curtis S
    Br J Gen Pract; 2008 Oct; 58(555):729; authore reply 729-30. PubMed ID: 18826786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.